Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by Bank of America from $665.00 to $680.00 in a research report report published on Friday, FlyOnTheWall reports. Other analysts have also recently issued reports about the stock. Morgan Stanley raised their price target on shares of Regeneron Pharmaceuticals from $897.00 to $912.00 and […]
Conning Inc. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 579 shares of the biopharmaceutical company’s stock after selling 70 shares during […]
Pflug Koory LLC trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.3% during the 2nd quarter, Holdings Channel reports. The fund owned 1,098 shares of the biopharmaceutical company’s stock after selling 15 shares during the period. Pflug Koory LLC’s holdings in Regeneron Pharmaceuticals were worth $789,000 as of its […]
Round Rock Advisors LLC lifted its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 27.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 460 shares of the biopharmaceutical company’s stock after purchasing an additional 100 shares during […]
ICICI Prudential Asset Management Co Ltd increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.5% during the second quarter, Holdings Channel.com reports. The institutional investor owned 733 shares of the biopharmaceutical company’s stock after buying an additional 45 shares during the quarter. ICICI Prudential Asset Management Co Ltd’s holdings […]